<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00184548</url>
  </required_header>
  <id_info>
    <org_study_id>F7TRAUMA-1711</org_study_id>
    <secondary_id>2005-002059-41</secondary_id>
    <nct_id>NCT00184548</nct_id>
  </id_info>
  <brief_title>Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding</brief_title>
  <acronym>CONTROL</acronym>
  <official_title>A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®/NiaStase®) in Severely Injured Trauma Patients With Bleeding Refractory to Standard Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novo Nordisk A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is conducted globally. The purpose of the trial is to evaluate that activated
      recombinant human factor VII (eptacog alfa (activated)) is safe and effective in severely
      injured trauma patients by assessing mortality and morbidity.

      Please note that this trial and trial F7TRAUMA-1648 (NCT00323570) have been merged.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The decision to discontinue the F7TRAUMA-1711 trial is not due to any safety concerns. The
      result of the pre-planned futility analysis performed in June 2008 predicted a very low
      likelihood of reaching a successful outcome on the primary efficacy endpoint at the end of
      the trial and as a consequence, the company has decided to close the trial as this juncture.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    See termination reason in detailed description
  </why_stopped>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>from day 0 to 30</time_frame>
    <description>Number of participants to die from day 0 to day 30 from all causes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>from day 0 to day 30</time_frame>
    <description>Morbidity reflects the number of patients who had pulmonary and/or renal dysfunction requiring ongoing medical intervention on day 30.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Days Alive and Free of Pulmonary and/or Renal Dysfunction Requiring Medical Intervention</measure>
    <time_frame>from day 0 to day 30</time_frame>
    <description>The number of days alive and free of pulmonary and/or renal dysfunction requiring medical intervention from day 0 to day 30.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Death From Time of First Dose</measure>
    <time_frame>from day 0 to day 30</time_frame>
    <description>The time of first dose refers to the time of the first dose of rFVIIa or placebo.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Units of Transfused Red Blood Cells From Time of First Dose</measure>
    <time_frame>from hour 0 to 24</time_frame>
    <description>The number of units of transfused red blood cells in the first 24 hours from the time of the first dose of rFVIIa or placebo.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Receiving 10 Units or More (Massive Transfusion) of Red Blood Cells From Time of Injury</measure>
    <time_frame>from hour 0 to 24</time_frame>
    <description>The number of patients receiving 10 units or more of red blood cells in the first 24 hours from the time of injury.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Units of All Allogeneic Transfusions From Time of First Dose</measure>
    <time_frame>from hour 0 to 24</time_frame>
    <description>The number of units of all allogeneic transfusions in the first 24 hours from the time of the first dose of rFVIIa or placebo.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">554</enrollment>
  <condition>Acquired Bleeding Disorder</condition>
  <condition>Trauma</condition>
  <arm_group>
    <arm_group_label>rFVIIa, Blunt Trauma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo, Blunt Trauma</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>rVIIa, Penetrating Trauma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo, Penetrating Trauma</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>eptacog alfa (activated)</intervention_name>
    <description>Sterile, freeze-dried powder in single-use vials to be reconstituted with sterile water for injection.
Three doses of 200, 100 and 100 mcg/kg to be administered bolus i.v. (intravenous) over approx. three hours.</description>
    <arm_group_label>rFVIIa, Blunt Trauma</arm_group_label>
    <arm_group_label>rVIIa, Penetrating Trauma</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebo, Blunt Trauma</arm_group_label>
    <arm_group_label>Placebo, Penetrating Trauma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Trauma injury (blunt and/or penetrating) with evidence of active hemorrhage (torso
             and/or proximal lower extremity) refractory to blood component therapy and surgical
             haemostatic procedures at the time of randomisation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Clinical Registry (GCR, 1452)</last_name>
    <role>Study Director</role>
    <affiliation>Novo Nordisk A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novo Nordisk Clinical Trial Call Center</name>
      <address>
        <city>Princeton</city>
        <state>New Jersey</state>
        <zip>08540</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Säo Paulo</city>
        <zip>05001-400</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Prague</city>
        <zip>16000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris La défense cedex</city>
        <zip>92932</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mainz</city>
        <zip>55127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vouliagment</city>
        <zip>16671</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kowloon</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest</city>
        <zip>1025</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rome</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alphen a/d Rijn</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sandton</city>
        <zip>2146</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madrid</city>
        <zip>28033</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <zip>CH-8050</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Crawley</city>
        <zip>RH11 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>Israel</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Singapore</country>
    <country>Slovenia</country>
    <country>Sweden</country>
    <country>Taiwan</country>
    <country>Turkey</country>
  </removed_countries>
  <link>
    <url>http://novonordisk-trials.com</url>
    <description>Clinical Trials at Novo Nordisk</description>
  </link>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <results_first_submitted>September 4, 2009</results_first_submitted>
  <results_first_submitted_qc>October 16, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 26, 2009</results_first_posted>
  <last_update_submitted>June 13, 2014</last_update_submitted>
  <last_update_submitted_qc>June 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>150 trial sites globally.</recruitment_details>
      <pre_assignment_details>Eligible subjects were those with either blunt and/or penetrating trauma injuries and confirmed clinical indicators for active haemorrhage refractory to standard treatment (including blood component therapy and surgical haemostatic procedures).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>rFVIIa, Blunt Trauma</title>
          <description>Three single doses of activated recombinant human factor VII (rFVIIa) (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
        <group group_id="P2">
          <title>Placebo, Blunt Trauma</title>
          <description>Three single doses of placebo (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
        <group group_id="P3">
          <title>rVIIa, Penetrating Trauma</title>
          <description>Three single doses of activated recombinant human factor VII (rFVIIa) (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
        <group group_id="P4">
          <title>Placebo, Penetrating Trauma</title>
          <description>Three single doses of placebo (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="226"/>
                <participants group_id="P2" count="255"/>
                <participants group_id="P3" count="47"/>
                <participants group_id="P4" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Exposed</title>
              <participants_list>
                <participants group_id="P1" count="224">Two subjects withdrew due to ineligibility. Excluded from safety analysis set</participants>
                <participants group_id="P2" count="250">Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set</participants>
                <participants group_id="P3" count="46">One subject withdrew due to ineligibility. Excluded from safety analysis set</participants>
                <participants group_id="P4" count="40">Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="218"/>
                <participants group_id="P2" count="242"/>
                <participants group_id="P3" count="44"/>
                <participants group_id="P4" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>rFVIIa, Blunt Trauma</title>
        </group>
        <group group_id="B2">
          <title>Placebo, Blunt Trauma</title>
        </group>
        <group group_id="B3">
          <title>rFVIIa, Penetrating Trauma</title>
        </group>
        <group group_id="B4">
          <title>Placebo, Penetrating Trauma</title>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="221"/>
            <count group_id="B2" value="247"/>
            <count group_id="B3" value="46"/>
            <count group_id="B4" value="40"/>
            <count group_id="B5" value="554"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.2" spread="14.4"/>
                    <measurement group_id="B2" value="39.9" spread="14.2"/>
                    <measurement group_id="B3" value="33.8" spread="11.9"/>
                    <measurement group_id="B4" value="29.4" spread="10.3"/>
                    <measurement group_id="B5" value="38.4" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="182"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="37"/>
                    <measurement group_id="B5" value="424"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mortality</title>
        <description>Number of participants to die from day 0 to day 30 from all causes.</description>
        <time_frame>from day 0 to 30</time_frame>
        <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set. Patients who discontinued (withdrawn or lost to follow up) before day 30 were excluded from analyses. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
        <group_list>
          <group group_id="O1">
            <title>rFVIIa, Blunt Trauma</title>
          </group>
          <group group_id="O2">
            <title>Placebo, Blunt Trauma</title>
          </group>
          <group group_id="O3">
            <title>rFVIIa, Penetrating Trauma</title>
          </group>
          <group group_id="O4">
            <title>Placebo, Penetrating Trauma</title>
          </group>
        </group_list>
        <measure>
          <title>Mortality</title>
          <description>Number of participants to die from day 0 to day 30 from all causes.</description>
          <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set. Patients who discontinued (withdrawn or lost to follow up) before day 30 were excluded from analyses. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="242"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Test for Odds ratio=1, corresponding to a null hypothesis of no difference in mortality for patients who died between groups for Blunt Trauma. Odds-ratio is adjusted for baseline covariates: Age, Injury Severity Score (ISS), Glasgow Coma ­Scale Score (GCS), International Normalized Ratio (INR) and acute lung injury (P/F &gt; 200). Missing covariates are imputed by the mean value.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.934</p_value>
            <p_value_desc>Two-sided significance level 5%</p_value_desc>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Treatment groups are compared using a Cox Proportional Hazards model with treatment as factor and adjusting for age, Injury Severity Score (ISS), Glasgow Coma ­Scale Score(GCS), International Normalized Ratio (INR) and acute lung injury.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.589</p_value>
            <p_value_desc>Two-sided significance level 5%</p_value_desc>
            <method>Cox Proportional Hazards Model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.18</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.64</ci_lower_limit>
            <ci_upper_limit>2.17</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Morbidity</title>
        <description>Morbidity reflects the number of patients who had pulmonary and/or renal dysfunction requiring ongoing medical intervention on day 30.</description>
        <time_frame>from day 0 to day 30</time_frame>
        <population>Blunt trauma patient population: According to protocol, morbidity is not part of the primary endpoint since non-inferiority test of mortality was not passed. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
        <group_list>
          <group group_id="O1">
            <title>rFVIIa, Blunt Trauma</title>
          </group>
          <group group_id="O2">
            <title>Placebo, Blunt Trauma</title>
          </group>
          <group group_id="O3">
            <title>rFVIIa, Penetrating Trauma</title>
          </group>
          <group group_id="O4">
            <title>Placebo, Penetrating Trauma</title>
          </group>
        </group_list>
        <measure>
          <title>Morbidity</title>
          <description>Morbidity reflects the number of patients who had pulmonary and/or renal dysfunction requiring ongoing medical intervention on day 30.</description>
          <population>Blunt trauma patient population: According to protocol, morbidity is not part of the primary endpoint since non-inferiority test of mortality was not passed. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Days Alive and Free of Pulmonary and/or Renal Dysfunction Requiring Medical Intervention</title>
        <description>The number of days alive and free of pulmonary and/or renal dysfunction requiring medical intervention from day 0 to day 30.</description>
        <time_frame>from day 0 to day 30</time_frame>
        <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
        <group_list>
          <group group_id="O1">
            <title>rFVIIa, Blunt Trauma</title>
          </group>
          <group group_id="O2">
            <title>Placebo, Blunt Trauma</title>
          </group>
          <group group_id="O3">
            <title>rFVIIa, Penetrating Trauma</title>
          </group>
          <group group_id="O4">
            <title>Placebo, Penetrating Trauma</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Days Alive and Free of Pulmonary and/or Renal Dysfunction Requiring Medical Intervention</title>
          <description>The number of days alive and free of pulmonary and/or renal dysfunction requiring medical intervention from day 0 to day 30.</description>
          <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="242"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.2" spread="10.3"/>
                    <measurement group_id="O2" value="16.4" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Baseline covariates: Age, Injury Severity Score (ISS), Glasgow Coma ­Scale Score (GCS), International Normalized Ratio (INR) and acute lung injury.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.308</p_value>
            <method>ANCOVA</method>
            <param_type>LS means</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.83</ci_lower_limit>
            <ci_upper_limit>2.63</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Death From Time of First Dose</title>
        <description>The time of first dose refers to the time of the first dose of rFVIIa or placebo.</description>
        <time_frame>from day 0 to day 30</time_frame>
        <population>There is no measure summary for time to event type of endpoint as this would be a Kaplan-Meier graph.</population>
        <group_list>
          <group group_id="O1">
            <title>rFVIIa, Blunt Trauma</title>
          </group>
          <group group_id="O2">
            <title>Placebo, Blunt Trauma</title>
          </group>
          <group group_id="O3">
            <title>rFVIIa, Penetrating Trauma</title>
          </group>
          <group group_id="O4">
            <title>Placebo, Penetrating Trauma</title>
          </group>
        </group_list>
        <measure>
          <title>Time to Death From Time of First Dose</title>
          <description>The time of first dose refers to the time of the first dose of rFVIIa or placebo.</description>
          <population>There is no measure summary for time to event type of endpoint as this would be a Kaplan-Meier graph.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Units of Transfused Red Blood Cells From Time of First Dose</title>
        <description>The number of units of transfused red blood cells in the first 24 hours from the time of the first dose of rFVIIa or placebo.</description>
        <time_frame>from hour 0 to 24</time_frame>
        <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set including patients who discontinued before day 30. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
        <group_list>
          <group group_id="O1">
            <title>rFVIIa, Blunt Trauma</title>
          </group>
          <group group_id="O2">
            <title>Placebo, Blunt Trauma</title>
          </group>
          <group group_id="O3">
            <title>rFVIIa, Penetrating Trauma</title>
          </group>
          <group group_id="O4">
            <title>Placebo, Penetrating Trauma</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Units of Transfused Red Blood Cells From Time of First Dose</title>
          <description>The number of units of transfused red blood cells in the first 24 hours from the time of the first dose of rFVIIa or placebo.</description>
          <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set including patients who discontinued before day 30. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
          <units>Units of transfused red blood cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
                <count group_id="O2" value="247"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="10.4"/>
                    <measurement group_id="O2" value="8.1" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.038</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Hodges-Lehmann shift estimate</param_type>
            <param_value>1.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0</ci_lower_limit>
            <ci_upper_limit>2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Receiving 10 Units or More (Massive Transfusion) of Red Blood Cells From Time of Injury</title>
        <description>The number of patients receiving 10 units or more of red blood cells in the first 24 hours from the time of injury.</description>
        <time_frame>from hour 0 to 24</time_frame>
        <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set including patients who discontinued before day 30. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
        <group_list>
          <group group_id="O1">
            <title>rFVIIa, Blunt Trauma</title>
          </group>
          <group group_id="O2">
            <title>Placebo, Blunt Trauma</title>
          </group>
          <group group_id="O3">
            <title>rFVIIa, Penetrating Trauma</title>
          </group>
          <group group_id="O4">
            <title>Placebo, Penetrating Trauma</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Receiving 10 Units or More (Massive Transfusion) of Red Blood Cells From Time of Injury</title>
          <description>The number of patients receiving 10 units or more of red blood cells in the first 24 hours from the time of injury.</description>
          <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set including patients who discontinued before day 30. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
                <count group_id="O2" value="247"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="111"/>
                    <measurement group_id="O2" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.384</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.175</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.817</ci_lower_limit>
            <ci_upper_limit>1.690</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Units of All Allogeneic Transfusions From Time of First Dose</title>
        <description>The number of units of all allogeneic transfusions in the first 24 hours from the time of the first dose of rFVIIa or placebo.</description>
        <time_frame>from hour 0 to 24</time_frame>
        <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set, including patients who discontinued before day 30. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
        <group_list>
          <group group_id="O1">
            <title>rFVIIa, Blunt Trauma</title>
          </group>
          <group group_id="O2">
            <title>Placebo, Blunt Trauma</title>
          </group>
          <group group_id="O3">
            <title>rFVIIa, Penetrating Trauma</title>
          </group>
          <group group_id="O4">
            <title>Placebo, Penetrating Trauma</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Units of All Allogeneic Transfusions From Time of First Dose</title>
          <description>The number of units of all allogeneic transfusions in the first 24 hours from the time of the first dose of rFVIIa or placebo.</description>
          <population>Blunt trauma patient population: Intention-to-treat (ITT) analysis set, including patients who discontinued before day 30. Penetrating Trauma patient population: No analysis done due to low statistical power.</population>
          <units>Units of allogeneic transfusions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="221"/>
                <count group_id="O2" value="247"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.1" spread="26.8"/>
                    <measurement group_id="O2" value="20.7" spread="25.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.030</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Hodges-Lehmann shift estimate</param_type>
            <param_value>2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0</ci_lower_limit>
            <ci_upper_limit>4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected in a timespan of 90 days.</time_frame>
      <desc>Safety population includes three patients in each blunt trauma treatment arm who were randomised received an initial dose and no further information is known. These patients were not included in the intent-to-treat (ITT) population.</desc>
      <group_list>
        <group group_id="E1">
          <title>rFVIIa, Blunt Trauma</title>
          <description>Three single doses of activated recombinant human factor VII (rFVIIa) (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
        <group group_id="E2">
          <title>Placebo, Blunt Trauma</title>
          <description>Three single doses of placebo (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
        <group group_id="E3">
          <title>rVIIa, Penetrating Trauma</title>
          <description>Three single doses of activated recombinant human factor VII (rFVIIa) (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
        <group group_id="E4">
          <title>Placebo, Penetrating Trauma</title>
          <description>Three single doses of placebo (200 mcg/kg, 100 mcg/kg, and 100 mcg/kg) administered over approximately three hours. First dose was administered within a maximum of 12 hours from injury. A second dose was to be administered one hour after the initial dose, and a third dose was to be administered three hours after the initial dose.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="147" subjects_at_risk="224"/>
                <counts group_id="E2" subjects_affected="177" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="224"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Idiopathic thrombocytopenic purpura</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Thrombocythaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="10" subjects_affected="7" subjects_at_risk="224"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="250"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Electromechanical dissociation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperadrenalism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ulcerative keratitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal compartment syndrome</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="224"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Duodenal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemorrhagic erosive gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intestinal fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oesophageal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peritoneal effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rectal fissure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Brain death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Extravasation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="224"/>
                <counts group_id="E2" events="18" subjects_affected="17" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ischaemic hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Acinetobacter infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Catheter related infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Enterococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pelvic abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pelvic infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="224"/>
                <counts group_id="E2" events="27" subjects_affected="26" subjects_at_risk="250"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pseudomonas infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="224"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="250"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Septic necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="224"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Skin graft infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Splenic abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Superinfection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Systemic candida</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="224"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound infection bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound infection pseudomonas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Anastomotic leak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Aortic injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Collapse of lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Diffuse axonal injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Endotracheal intubation complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Failure to anastomose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Fat embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Graft thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Iatrogenic injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Inadequate analgesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Skin injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Tracheal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Traumatic liver injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urinary bladder rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vascular injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vena cava injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vertebral injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Weaning failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wound decomposition</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Cardiac output decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Sputum culture positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Muscle necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Musculoskeletal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pelvic deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Soft tissue necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cerebral hygroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Anoxic encephalopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Brain stem haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Critical illness polyneuropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neuromyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Paraplegia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Quadriparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Subdural effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vocal cord paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Urinary fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Female genital tract fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pelvic haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="224"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="224"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="224"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Internal fixation of fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Leg amputation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Arterial haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="224"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Exsanguination</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemodynamic instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="224"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pelvic venous thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peripheral artery dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Vena cava thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Venous haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="108" subjects_at_risk="224"/>
                <counts group_id="E2" subjects_affected="125" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="46"/>
                <counts group_id="E4" subjects_affected="24" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="224"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="250"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="224"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="250"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="224"/>
                <counts group_id="E2" events="22" subjects_affected="21" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="224"/>
                <counts group_id="E2" events="29" subjects_affected="27" subjects_at_risk="250"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="46"/>
                <counts group_id="E4" events="14" subjects_affected="14" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="224"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="224"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="250"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="28" subjects_affected="28" subjects_at_risk="224"/>
                <counts group_id="E2" events="33" subjects_affected="32" subjects_at_risk="250"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="46"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="224"/>
                <counts group_id="E2" events="28" subjects_affected="28" subjects_at_risk="250"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="46"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="224"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="250"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="250"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="46"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="224"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="250"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial in accordance with the latest Vancouver guidelines. Any such scientific paper, resentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication / presentation for comments. Comments will be given within four weeks from receipt of the manuscript.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Trial was terminated after planned interim analysis for futility showed a lower than expected conditional power for showing superiority (11.2% [actual] vs. 50% [required]). 554 of 1502 planned patients were included in the intent-to-treat population.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Public Access to Clinical Trials</name_or_title>
      <organization>Novo Nordisk A/S</organization>
      <email>clinicaltrials@novonordisk.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

